Власов П.В. Лучевая диагностика заболеваний органов грудной полости.- Видар, 2006 - С 65-77.
Изаксон Э. О патолого-анатомических изменениях легочных сосудов при эмфизематозном процессе в легких // Пульмон.- 2005.- № 4б. - С.41-52.
American Thoracic Society. Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency // Am. J. Respir. Crit Care Med.- 2003. - Vol. 168. - P. 818-900.
Aoshiba K, Nagai A. Differences in airway remodeling between asthma and chronic obstructive pulmonary disease //Clin. Rev. Allergy Immunol. - 2004. - Vol. 27. - P. 35-43.
Barnes P. J., Stockley R. A. COPD: current therapeutic interventions and future approaches // Eur. Respir. J. - 2005. - Vol. 25. - P. 1084-1106.
Beeh KM, Beier J, Kornmann O, Buhl R Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1 and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects // Respir. Med. - 2003. - Vol. 97. - P. 634-639.
Bonniaud P, Kolb M, Galt T et al: Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis //J. Immunol. - 2004. - Vol. 173. - P. 2099-2108.
Brantigan O, Mueller E. Surgical treatment of pulmonary emphysema // Am. Surg. - 1957. - Vol. 23. - P. 789-804.
Carp H., Miller F., Hoidal J.R., Janoff A. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity // Proc. Natl. Acad. Sci. USA. - 1982. - Vol. 79. - P. 2041-2045.
Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease // N. Engl. J. Med. - 2004. - Vol. 350. - P. 1005-1012.